Implications of Some Selected Flavonoids Towards Alzheimer’s Disease with the Emphasis on Cholinesterase Inhibition and their Bioproduction by Metabolic Engineering

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|15|4|352-361

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.4, 2014-04, pp. : 352-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selectivity of Cholinesterase Inhibition: Clinical Implications for the Treatment of Alzheimer’s Disease

By Weinstock M.  

CNS Drugs, Vol. 12, Iss. 4, 1999-10 ,pp. : 307-323

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease

By Thompson Sarah   Lanctôt Krista L   Herrmann Nathan  

Expert Opinion on Drug Safety, Vol. 3, Iss. 5, 2004-09 ,pp. : 425-440

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Cholinesterase Inhibitor Treatment of Alzheimer’s Disease

By Peter Johannsen  

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 757-768

Adis International

Access to resources Recommend Favorite

The Role of Bridging Studies in the Development of Cholinesterase Inhibitors for Alzheimer’s Disease

By Cutler N.R.   Sramek J.J.  

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 355-364

Adis International

Access to resources Recommend Favorite